We are live on ! Find out more
SM

Sabby Management Portfolio holdings

AUM $45.1M
1-Year Est. Return 74.25%
This Fund
S&P 500
This Quarter Est. Return
-26.15%
1 Year Est. Return
-74.25%
3 Year Est. Return
-95.86%
5 Year Est. Return
-99.36%
10 Year Est. Return
-99.46%
AUM
$114M
AUM Growth
+$34.8M
Cap. Flow
+$5.97M
Cap. Flow %
5.23%
Top 10 Hldgs %
76.84%
Holding
142
New
26
Increased
18
Reduced
48
Closed
32

Top Buys

Rank Stock Value
1
TC
TuanChe
TC
+$10.2M
2
HUDI icon
Huadi International Group
HUDI
+$5.7M
3
MTVA
MetaVia Inc
MTVA
+$4.11M
4
RDHL
Redhill Biopharma
RDHL
+$3.23M
5
IWM icon
iShares Russell 2000 ETF
IWM
+$1.96M

Top Sells

Rank Stock Value
1
MMAT
Meta Materials Inc. Common Stock
MMAT
+$1.82M
2
BGXX
Bright Green Corporation Common Stock
BGXX
+$1.68M
3
PMCB icon
PharmaCyte Biotech
PMCB
+$1.34M
4
RCON icon
Recon Technology
RCON
+$1.12M
5
BLRX
BioLineRX
BLRX
+$953K

Sector Composition

Rank Sector Weight
1 Healthcare 15.91%
2 Industrials 2.97%
3 Technology 2.61%
4 Communication Services 2.07%
5 Consumer Discretionary 2.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SPY icon
1
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$784B
$38.2M 33.54%
1,000
-518
-34% -$199K
OEF icon
2
PUT
iShares S&P 100 ETF
OEF
$19.9B
$31.3M 27.42%
1,793
+1,404
+361% +$242K
NVCT icon
3
Nuvectis Pharma
NVCT
$718M
$4.41M 3.86%
587,452
-45,527
-7% -$326K
TBLT
4
DELISTED
ToughBuilt Industries, Inc. Common Stock
TBLT
$2.28M 2%
14,975
+8,287
+124% +$1.21M
ATNM icon
5
PUT
Actinium Pharmaceuticals
ATNM
$26.3M
$2.05M 1.79%
1,921
-222
-10% -$2.25K
DOGZ icon
6
Dogness International Corp
DOGZ
$12.8M
$2.04M 1.79%
103,939
-17,578
-14% -$347K
TC
7
TuanChe
TC
$55.8M
$2.03M 1.78%
+8,098
New +$10.2M
IWM icon
8
iShares Russell 2000 ETF
IWM
$80.2B
$1.92M 1.68%
+11,000
New +$1.96M
AKTX
9
Akari Therapeutics
AKTX
$14M
$1.72M 1.51%
4,585
-544
-11% -$225K
BCTXW
10
PUT
DELISTED
BriaCell Therapeutics Corp Warrant
BCTXW
$1.67M 1.46%
3,815
-1,846
-33% -$4.3K
HUDI icon
11
Huadi International Group
HUDI
$10.3M
$1.48M 1.3%
+291,609
New +$5.7M
SPY icon
12
State Street SPDR S&P 500 ETF Trust
SPY
$784B
$1.28M 1.12%
+3,350
New +$1.29M
AVCT
13
DELISTED
American Virtual Cloud Technologies, Inc. Common Stock
AVCT
$1.26M 1.11%
+1,100,000
New +$1.38M
PULM icon
14
Pulmatrix
PULM
$6.21M
$1.17M 1.03%
301,943
-10,057
-3% -$36.4K
RDHL
15
Redhill Biopharma
RDHL
$3.84M
$1.05M 0.92%
+7,450
New +$3.23M
BLRX
16
BioLineRX
BLRX
$11.7M
$1.03M 0.91%
43,800
-32,053
-42% -$953K
MMAT
17
PUT
DELISTED
Meta Materials Inc. Common Stock
MMAT
$1.03M 0.9%
86
+47
+121% +$6.21K
BGXX
18
DELISTED
Bright Green Corporation Common Stock
BGXX
$874K 0.77%
1,861,827
-2,900,078
-61% -$1.68M
COCP icon
19
Cocrystal Pharma
COCP
$12M
$820K 0.72%
420,710
-19,645
-4% -$50.4K
ESPR
20
PUT
DELISTED
Esperion Therapeutics
ESPR
$735K 0.64%
1,179
+999
+555% +$7.14K
SCNI
21
Scinai Immunotherapeutics
SCNI
$1.43M
$653K 0.57%
+22,056
New +$1.66M
ONCO icon
22
Onconetix
ONCO
$2.9M
$620K 0.54%
3
– –
VRPX
23
DELISTED
Virpax Pharmaceuticals, Inc. Common Stock
VRPX
$615K 0.54%
3,953
-265
-6% -$60.4K
AIOS
24
AIOS Tech
AIOS
$38.8M
$610K 0.53%
5,353
-5,532
-51% -$617K
MTVA
25
MetaVia Inc
MTVA
$7.44M
$604K 0.53%
+9,566
New +$4.11M
1
2 3 4 5

Similar funds

CG
Circumference Group Little Rock, Arkansas $44.6M AUM 5.21% 1-Year Est. Return
OC
Optimas Capital Central, Hong Kong $44.5M AUM 24.43% 1-Year Est. Return
ICCON
Investment Counsel Company of Nevada Las Vegas, Nevada $44.5M AUM 21.97% 1-Year Est. Return
PCM
Prentice Capital Management Greenwich, Connecticut $45.7M AUM 2.65% 1-Year Est. Return
CAS
CTC Alternative Strategies Chicago, Illinois $44M AUM 43.15% 1-Year Est. Return
CM
Crestline Management Fort Worth, Texas $46.3M AUM 48.82% 1-Year Est. Return
MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return
AB
Aozora Bank Tokyo, Japan $43.6M AUM 1.15% 1-Year Est. Return

Sabby Management's Q4 2022 Portfolio in Review

As of Q4 2022, Sabby Management held 142 positions worth $114M, up 44% from $79.3M the previous quarter. Its ten largest holdings account for 77% of the portfolio.

Sabby Management deployed $5.97M of net new capital in Q4 2022, opening 26 new positions and adding to 18 existing holdings. Its largest new stake was TuanChe: 8,098 shares worth $2.03M.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, down from 37% a quarter earlier, followed by Industrials and Technology.

On the sell side, the largest reduction was Bright Green Corporation Common Stock, an estimated $1.68M trimmed.

  • Sabby Management's largest Q4 2022 buy was TuanChe: 8,098 shares worth $2.03M.
  • Sabby Management added most to ToughBuilt Industries, Inc. Common Stock in Q4 2022, an estimated $1.21M increase.
  • Sabby Management's biggest Q4 2022 reduction was Bright Green Corporation Common Stock, cutting an estimated $1.68M.
  • Sabby Management fully exited Meta Materials Inc. Common Stock in Q4 2022, selling an estimated $1.82M.
  • Sabby Management's ten largest holdings make up 77% of its $114M portfolio in Q4 2022.
  • Sabby Management opened 26 new positions and closed 32 in Q4 2022.
  • Sabby Management's portfolio value rose 44% quarter-over-quarter to $114M.

Based on Sabby Management's 13F filing for Q4 2022, filed 14 Feb 2023.